⌘K

Login Start Free

Home/Filings/4/0001225208-23-005181

4//SEC Filing

SELLERS ROBERT W.A. 4

Accession 0001225208-23-005181

CIK 0001099800other

View on SEC.gov Company Profile

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 7:08 PM ET

Size

8.9 KB

Accession

0001225208-23-005181

Insider Transaction Report

Form 4

Period: 2023-04-28

Edwards Lifesciences CorpEW

SELLERS ROBERT W.A.

VP, Corporate Controller

Transactions

Exercise/Conversion
Common Stock
2023-04-28$35.20/sh+12,270$431,864→ 24,019.79 total
Sale
Common Stock
2023-04-28$87.20/sh−12,270$1,069,944→ 11,749.79 total
Exercise/Conversion
Employee Stock Option (Right to Acquire)
2023-04-28−12,270→ 0 total
Exercise: $35.20From: 2017-05-12Exp: 2023-05-11→ Common Stock (12,270 underlying)

Holdings

Common Stock
(indirect: By Trust)
20,409

Documents

1 file

4
doc4.xmlPrimary

Issuer

Edwards Lifesciences Corp

CIK 0001099800

Entity typeother

Related Parties

1

filerCIK 0001600739

Filing Metadata

Form type: 4
Filed: Apr 27, 8:00 PM ET
Accepted: Apr 28, 7:08 PM ET
Size: 8.9 KB

View on SEC.gov